Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the JDRF lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
The focus of this event is ‘type 1 technology’ covering aspects such as access, choice, and everyday living with type 1 technology.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About JDRF & Our Impact > Our research > Research projects > Creating a more human-like environment to grow beta cells
Dr Rocio Sancho, a type 1 diabetes researcher at Kings College London.
Beta cells are the cells in the pancreas that produce insulin and are destroyed by the immune system in type 1 diabetes. For many people, a cure for type 1 would be to have a population of functional beta cells again. One way to achieve this is by growing new beta cells in a lab from human stem cells, which can develop into most other cell types.
Currently, the beta cells that researchers can grow in labs can’t function well enough to produce and release the amount of insulin needed by someone with type 1. So, researchers are trying to improve the quality of lab-grown beta cells in different ways. Rocio’s lab group is focusing on the gel that the cells are grown in to try and produce better quality beta cells.
To grow beta cells, stem cells are placed in a gel that mimics the environment in which beta cells develop in the body. Until now, researchers have used a gel derived from animals, which limits their use for treating people with type 1. So, Rocio’s team has been developing their own gel to mimic the environment found in the human body, rather than that of other animals. Rocio’s team are adjusting the different proteins in their gel slightly to create the best possible environment for the beta cells.
Next, the researchers will select the optimal mix of proteins for their gel. Then they will use their specialised gel to grow another batch of beta cells from stem cells. They hope their gel will mimic the natural environment of the human pancreas well enough to allow these beta cells to reach full maturity. They will assess this by testing whether their lab-grown cells can behave as completely mature and effective beta cells by stabilising blood glucose levels.
Rocio’s research will bring us closer to growing beta cells that are effective enough to cure type 1 diabetes. Her team hopes to develop a gel that enables researchers to grow beta cells that accurately mimic those found in people without type 1. They will share the recipe for their gel with other researchers so that labs across the world can use it to grow the best possible beta cells.
Another researcher we are funding who is trying to grow beta cells is Dr Fiona Docherty. As well as growing new beta cells, we also fund research to protect existing beta cells. An example of this is Dr Gavin Bewick, who is developing a new drug that he hopes will protect beta cells from being destroyed by the immune system in type 1.
This award will help to fund the next generation of immunotherapy research, enabling more efficient clinical trials, in more locations, so that promising treatments can reach people sooner.
This project aims to overcome two major roadblocks to developing and licensing immunotherapies for people newly diagnosed with type 1 diabetes.
Dr Bewick is exploring ways to improve the health, performance and number of beta cells in the body, so that people with type 1 can be less reliant on insulin pumps and injections – or even, one day, live without them completely.
This project is looking at a new way to turn stem cells into beta cells in the lab, to better understand what conditions make this process happen efficiently.
